These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 17676726)

  • 41. Identification of a series of benzoxazoles as potent 5-HT6 ligands.
    Liu KG; Lo JR; Comery TA; Zhang GM; Zhang JY; Kowal DM; Smith DL; Di L; Kerns EH; Schechter LE; Robichaud AJ
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1115-7. PubMed ID: 19152787
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A conservative, single-amino acid substitution in the second cytoplasmic domain of the human Serotonin2C receptor alters both ligand-dependent and -independent receptor signaling.
    Berg KA; Dunlop J; Sanchez T; Silva M; Clarke WP
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1084-92. PubMed ID: 18065501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pyrido[2,3-e]-1,2,4-triazolo[4,3-a]pyrazin-1-one as a new scaffold to develop potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Lenzi O; Catarzi D; Varano F; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Traini C; Pedata F; Morizzo E; Moro S
    J Med Chem; 2009 Apr; 52(8):2407-19. PubMed ID: 19301821
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and evaluation of homodimeric GnRHR antagonists having a rigid bis-propargylated benzene core.
    Bonger KM; van den Berg RJ; Knijnenburg AD; Heitman LH; Ijzerman AP; Oosterom J; Timmers CM; Overkleeft HS; van der Marel GA
    Bioorg Med Chem; 2008 Apr; 16(7):3744-58. PubMed ID: 18282756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multivalent approach to the design and discovery of orally efficacious 5-HT4 receptor agonists.
    McKinnell RM; Armstrong SR; Beattie DT; Choi SK; Fatheree PR; Gendron RA; Goldblum A; Humphrey PP; Long DD; Marquess DG; Shaw JP; Smith JA; Turner SD; Vickery RG
    J Med Chem; 2009 Sep; 52(17):5330-43. PubMed ID: 19663444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibitors of GlyT1 affect glycine transport via discrete binding sites.
    Mezler M; Hornberger W; Mueller R; Schmidt M; Amberg W; Braje W; Ochse M; Schoemaker H; Behl B
    Mol Pharmacol; 2008 Dec; 74(6):1705-15. PubMed ID: 18815213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of potent and selective serotonin 5-HT1B receptor ligands.
    Huang Y; Bae SA; Roth BL; Laruelle M
    Bioorg Med Chem Lett; 2005 Nov; 15(21):4786-9. PubMed ID: 16143528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers.
    Dubost E; Dumas N; Fossey C; Magnelli R; Butt-Gueulle S; Ballandonne C; Caignard DH; Dulin F; Sopkova de-Oliveira Santos J; Millet P; Charnay Y; Rault S; Cailly T; Fabis F
    J Med Chem; 2012 Nov; 55(22):9693-707. PubMed ID: 23102207
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis and preliminary screening of novel indole-3-methanamines as 5-HT4 receptor ligands.
    Hanna-Elias A; Manallack DT; Berque-Bestel I; Irving HR; Coupar IM; Iskander MN
    Eur J Med Chem; 2009 Jul; 44(7):2952-9. PubMed ID: 19223092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of modifications in imide fragment structure on 5-HT(1A) and 5-HT(7) receptor affinity and in vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines.
    Paluchowska MH; Bugno R; Duszyńska B; Tatarczyńska E; Nikiforuk A; Lenda T; Chojnacka-Wójcik E
    Bioorg Med Chem; 2007 Nov; 15(22):7116-25. PubMed ID: 17825569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 1,3-Dioxolane-based ligands as rigid analogues of naftopidil: structure-affinity/activity relationships at alpha1 and 5-HT1A receptors.
    Sorbi C; Franchini S; Tait A; Prandi A; Gallesi R; Angeli P; Marucci G; Pirona L; Poggesi E; Brasili L
    ChemMedChem; 2009 Mar; 4(3):393-9. PubMed ID: 19152363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [N-methyl-3H3]AZ10419369 binding to the 5-HT1B receptor: in vitro characterization and in vivo receptor occupancy.
    Maier DL; Sobotka-Briner C; Ding M; Powell ME; Jiang Q; Hill G; Heys JR; Elmore CS; Pierson ME; Mrzljak L
    J Pharmacol Exp Ther; 2009 Jul; 330(1):342-51. PubMed ID: 19401496
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel sigma receptor ligands: synthesis and biological profile.
    Prezzavento O; Campisi A; Ronsisvalle S; Li Volti G; Marrazzo A; Bramanti V; Cannavò G; Vanella L; Cagnotto A; Mennini T; Ientile R; Ronsisvalle G
    J Med Chem; 2007 Mar; 50(5):951-61. PubMed ID: 17328523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Allosteric ligands for the corticotropin releasing factor type 1 receptor modulate conformational states involved in receptor activation.
    Hoare SR; Fleck BA; Gross RS; Crowe PD; Williams JP; Grigoriadis DE
    Mol Pharmacol; 2008 May; 73(5):1371-80. PubMed ID: 18239030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of TD-8954, a clinical stage 5-HT(4) receptor agonist with gastrointestinal prokinetic properties.
    McKinnell RM; Armstrong SR; Beattie DT; Fatheree PR; Long DD; Marquess DG; Shaw JP; Vickery RG
    Bioorg Med Chem Lett; 2013 Jul; 23(14):4210-5. PubMed ID: 23756062
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of a novel 5-HT(4) receptor splice variant (r5-HT(4c1)) and preliminary characterisation of specific 5-HT(4a) and 5-HT(4b) receptor antibodies.
    Ray AM; Kelsell RE; Houp JA; Kelly FM; Medhurst AD; Cox HM; Calver AR
    Eur J Pharmacol; 2009 Feb; 604(1-3):1-11. PubMed ID: 19100256
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 5-Amino-6-chloro-N-[(1-isobutylpiperidin-4-yl)methyl]-2-methylimidazo[1,2-alpha]pyridine-8-carboxamide (CJ-033,466), a novel and selective 5-hydroxytryptamine4 receptor partial agonist: pharmacological profile in vitro and gastroprokinetic effect in conscious dogs.
    Mikami T; Ochi Y; Suzuki K; Saito T; Sugie Y; Sakakibara M
    J Pharmacol Exp Ther; 2008 Apr; 325(1):190-9. PubMed ID: 18198343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
    Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
    Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. (Phenylpiperazinyl-butyl)oxindoles as selective 5-HT7 receptor antagonists.
    Volk B; Barkóczy J; Hegedus E; Udvari S; Gacsályi I; Mezei T; Pallagi K; Kompagne H; Lévay G; Egyed A; Hársing LG; Spedding M; Simig G
    J Med Chem; 2008 Apr; 51(8):2522-32. PubMed ID: 18361484
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of extracellular domain dimerization in agonist-induced activation of natriuretic peptide receptor A.
    Parat M; McNicoll N; Wilkes B; Fournier A; De Léan A
    Mol Pharmacol; 2008 Feb; 73(2):431-40. PubMed ID: 17965196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.